N-Terminal Pro-B-Type Natriuretic Peptide and Echocardiographic Abnormalities in Severely Obese Patients: Correlation with Visceral Fat To the Editor: B-Type natriuretic peptide (BNP) and its co-released peptide N-termi-

References 1. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Sawamura T, et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999;99:3110–7. 2. Kume N, Kita T. Roles of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) and its soluble forms in atherogenesis. Curr Opin Lipidol 2001;12:419–23. 3. Murase T, Kume N, Kataoka H, Minami M, Sawamura T, Masaki T, Kita T. Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler Thromb Vasc Biol 2000;20: 715–20. 4. Hayashida K, Kume N, Murase T, Minami M, Nakagawa D, Inada T, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation 2005;112:812–8. 5. Hayashida K, Kume N, Minami M, Kita T. Lectinlike oxidized LDL receptor-1 (LOX-1) supports adhesion of mononuclear leukocytes and a monocytes-like cell line THP-1 cells under static and flow conditions. FEBS Letters 2002;511: 133–8. 6. Ishikawa E, Imagawa M, Hashida S, Yoshitake S, Hamaguchi Y, Ueno T. Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. J Immunoassay 1983;4:209–327.